Search
Eftrenonacog alfa
go.drugbank.com/drugs/DB11608ApprovedEftrenonacog alfa was developed and marketed as Alprolix for intravenous injection by Biogen. It was first approved by the FDA in March 2014 and later approved by the EMA in May 2016. … It is an X-linked genetic disease caused by mutation of the gene for coagulation protein factor IX (FIX), leading to decreased levels of endogenous factor IX and increased susceptibility to recurrent bleeding
Products: ALPROLIX® 250 UIPseudoephedrine
go.drugbank.com/drugs/DB00852ApprovedPseudoephedrine is structurally related to [ephedrine] but exerts a weaker effect on the sympathetic nervous system.
Mixtures: ASPIRIN COMPLEX 500 MG/30 MG ORAL SUSPANSIYON ICIN GRANUL ICEREN SASE, 10 ADET, ASPIRIN COMPLEX 500 MG/30 MG ORAL SUSPANSIYON ICIN GRANUL ICEREN SASE, 20 ADETProducts: Up and Up Suphedrine, UP AND UP nasal decongestantStreptokinase
go.drugbank.com/drugs/DB00086ApprovedInvestigationalWithdrawnStreptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.
Products: KABIKINASE 1.500.000 UI. POLVO PARA INYECCION, KABIKINASE AMPOLLAS DE 750.000 UI POLVO PµRA INYECCIONAllantoin
go.drugbank.com/drugs/DB11100ApprovedInvestigationalThe concentration of allantoin in muscles increases from a resting value of about 5000 ug/kg to about 16000 ug/kg immediately after short-term exhaustive cycling exercise [FDA Label].
Mixtures: Dr.g Whitening Fortifier By Egf, Dr.g Dewrinkle Fortifier By EgfProducts: Up and Up Advanced Scar, U-max Multi BBVasopressin
go.drugbank.com/drugs/DB00067ApprovedInvestigational[A228013] Despite a wide variety of functions, exogenous vasopressin is primarily used to control blood pressure during systemic shock by increasing vasoconstriction and renal fluid reuptake by acting … [A228013] It is currently marketed under the trademark VASOSTRICT® by PAR Pharmaceuticals.[L31413]
Products: VASOPRESINA 20 UI/ML, VASOPRESSIN INJECTION USP 20 u/mlMoroctocog alfa
go.drugbank.com/drugs/DB13999ApprovedMoroctocog alfa is identical in sequence to endogenously produced Factor VIII, but does not contain the B-domain, which has no known biological function. … Moroctocog alfa is approved by Health Canada and by the European Medicines Agency for the control and prevention of hemorrhagic episodes and for routine and surgical prophylaxis in patients with hemophilia
Products: XYNTHA® 2000 UI, XYNTHA® 250 UI POLVO LIOFILIZADO PARA SOLUCION INYECTABLEAntihemophilic factor, human recombinant
go.drugbank.com/drugs/DB00025ApprovedInvestigationalHuman recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells
Products: ADVATE® 250 UI, ADVATE® 500 UIOctasulfur
go.drugbank.com/drugs/DB09353ApprovedPeople take sulfur by mouth for shortness of breath, allergies, swelling in the back of the throat (pharyngitis), high cholesterol, clogged arteries, menopause, and upper respiratory tract infections like
Products: Overnight Spot Treatment, Liquimat Acne Treatment and Cover-UPCarbopol 974P
go.drugbank.com/drugs/DB05384ApprovedWithdrawnThe compound, known as BufferGel, was in advanced clinical trials for its ability to prevent pregnancy, but was discontinued. … It was under development by ReProtect LLC. It is a gel that may help both block the spread of sexually transmitted diseases and reduce unwanted pregnancies.
Products: LIQUIGEL UD 2.5MG/G EINZELOxytocin
go.drugbank.com/drugs/DB00107ApprovedInvestigationalVet approvedOxytocin should be used judiciously only when necessary and by experienced healthcare practitioners. … [A229008,A228593] In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recognized with a Nobel prize for his work.
Products: OXITOCINA 10 UI, OXITOCINA INYECCION 10 UI